FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine and describes a solution for producing an inhalation preparation containing fenoterol hydrobromide as an active agent, purified water and excipients with the excipients presented by sodium benzoate, an acidity regulator representing an organic acid in the following proportions, mg/ml: fenoterol hydrobromide 1.0-1.1; sodium benzoate 0.2-2.0; organic acid 1.4-1.7; purified water the rest provided pH makes 3.2-3.5.
EFFECT: solution has the high value of respirable fractions and high stability.
6 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
STABLE COMBINED SOLUTION OF FENOTEROL HYDROBROMIDE AND IPRATROPIUM BROMIDE | 2012 |
|
RU2493827C1 |
IPRATROPIUM BROMIDE SOLUTION | 2012 |
|
RU2496477C1 |
AEROSOL PREPARATION BASED ON FENOTEROL HYDROBROMIDE FOR TREATING RESPIRATORY DISEASES | 2015 |
|
RU2577289C1 |
COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
PHARMACEUTICAL INHALED MEDICATION FOR TREATMENT OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE, CONTAINING MICRONISED TIOTROPIUM BROMIDE AS ACTIVE SUBSTANCE AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2522213C2 |
INHALATION PREPARATION FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2510267C2 |
INHALATION PREPARATION FOR TREATING BRONCHAIL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2504382C1 |
INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT | 2012 |
|
RU2494730C1 |
INHALATION FORMULATION IN FORM OF AEROSOL FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2504402C1 |
AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
Authors
Dates
2013-04-20—Published
2012-05-29—Filed